 |
 |
Search
- Page Path
-
- HOME
- Search
- IBD
- Drug therapy and monitoring for inflammatory bowel disease: a multinational questionnaire investigation in Asia
- Chenwen Cai, Juntao Lu, Lijie Lai, Dongjuan Song, Jun Shen, Jinlu Tong, Qing Zheng, Kaichun Wu, Jiaming Qian, Zhihua Ran
- Intest Res. 2022;20(2):213-223. Published online April 29, 2022
- Full text PubReader ePub PDF Supplementary Material
- Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study
- Sun-Ho Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
- Intest Res. 2022;20(2):203-212. Published online April 29, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Perspectives of East Asian patients and physicians on complementary and alternative medicine use for inflammatory bowel disease: results of a cross-sectional, multinational study
- Eun Soo Kim, Chung Hyun Tae, Sung-Ae Jung, Dong Il Park, Jong Pil Im, Chang Soo Eun, Hyuk Yoon, Byung Ik Jang, Haruhiko Ogata, Kayoko Fukuhara, Fumihito Hirai, Kazuo Ohtsuka, Jing Liu, Qian Cao, on behalf of the Clinical Research Committee of the Asian Organization for Crohn’s and Colitis
- Intest Res. 2022;20(2):192-202. Published online April 29, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
- Sang Hyoung Park
- Intest Res. 2022;20(2):159-164. Published online April 29, 2022
- Full text PubReader ePub PDF
|
|
- Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?
- Yong Eun Park
- Intest Res. 2022;20(2):157-158. Published online April 29, 2022
- Full text PubReader ePub PDF
|
|
- 0. Is fecal microbiota transplantation effective in corticosteroid-dependent ulcerative colitis?
- Published online April 29, 2022
-
|
|
- IBD
- Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care
- Alex Barnes, David Carter, Patricia Kaazan, Alissa Walsh, Susan Connor, Jane M Andrews
- Intest Res. 2022;20(4):506-508. Published online April 26, 2022
- Full text PubReader ePub PDF
|
|
- The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
- Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, John R Fullarton, Edouard Louis, Fernando Magro, Juan Ricardo Marquez, Alexander R Moschen, Neeraj Narula, Grazyna Rydzewska, Axel U Dignass, Simon PL Travis
- Intest Res. 2023;21(1):161-167. Published online April 18, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Gastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysis
- Jong Yop Pae, Eun Soo Kim, Sung Kook Kim, Min Kyu Jung, Jun Heo, Jang Hoon Lee, Min Ae Park
- Intest Res. 2022;20(4):482-494. Published online April 15, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- IBD
- Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
- Haruka Otake, Satohiro Matsumoto, Hirosato Mashima
- Intest Res. 2022;20(4):464-474. Published online March 31, 2022
- Full text PubReader ePub PDF
|
|
- Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests
- José María Paredes, Tomás Ripollés, Ángela Algarra, Rafael Diaz, Nadia Moreno, Patricia Latorre, María Jesús Martínez, Pilar Llopis, Antonio López, Eduardo Moreno-Osset
- Intest Res. 2022;20(3):361-369. Published online March 15, 2022
- Full text PubReader ePub PDF
|
|
- Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
- Toshifumi Hibi, Satoshi Motoya, Tadakazu Hisamatsu, Fumihito Hirai, Kenji Watanabe, Katsuyoshi Matsuoka, Masayuki Saruta, Taku Kobayashi, Brian G Feagan, Chantal Tasset, Robin Besuyen, Chohee Yun, Gerald Crans, Jie Zhang, Akira Kondo, Mamoru Watanabe
- Intest Res. 2023;21(1):110-125. Published online March 11, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis
- Katsuyoshi Matsuoka, Kanae Togo, Noritoshi Yoshii, Masato Hoshi, Shoko Arai
- Intest Res. 2023;21(1):88-99. Published online March 11, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
- Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park
- Intest Res. 2022;20(4):452-463. Published online March 11, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know
- Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Seung-Jae Myung, Clinical Practice Guideline Committee of the Korean Association for the Study of Intestinal Diseases
- Intest Res. 2022;20(3):386-388. Published online March 11, 2022
- Full text PubReader ePub PDF
|
|
- Editorial Office
-
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145 Fax: +82-2-957-6146 E-mail: thekasid@irjournal.org
Copyright © 2024 by Korean Association for the Study of Intestinal Diseases.
